Professional Documents
Culture Documents
(repetita juvant)
Roberto Furlan, San Raffaele Scientific Institute
Dendritic lymphatics
cell
costimulus
inflammation!
Naïve T
Induction site lymphocyte
drugs
oligo
Activated
M A N T lymphocytes
blood stream
Target organ
Basis of immune-privilege
MS MS
The Immune-privileged
Status of the Brain is
not Absolute
• CNS is not drained by a fully developed
lymphatic vasculature:
• There are no classical lymphatic vessels in the brain
but there are other routes to channel CNS interstitial
fluid into lymph and blood circulation (Bradbury et al.,
1980; Widner et al., 1988; Cserr et al., 1992)
CSF/Brain-Lymph Node Routes
• Brain-lymph nodes (cerebral interstitial fluid):
via cerebral perivascular spaces plus
passage from subarachnoid space of Brain CSF
olfactory lobes into submucous spaces of
nose and thus to lymph (Bradbury et al.,
1981).
• CSF-lymph nodes (CSF circuit): via
prolongations of subarachnoid space around
Regional
the olfactory nerves leading into the Blood
Lymph Nodes
interstitial spaces of the nasal submucosa
(Bradbury and Westrop, 1983).
• Antigen-specific responses occur in the deep
cervical lymph nodes after intracerebral
antigen deposition (Widner et al., 1988).
• Antigens deposited in the lateral ventricles Spleen
drain preferentially to the blood with a high
response in the spleen (Widner et al., 1988).
Indian Ink: Interstitial Fluid Bulk
Flow along the Perivascular route
Injection
MCA
Perivascular Bulk Flow
Routes for Interstitial Fluid Tracer
Artery
Capillary
Tracer
Entry of Lymphocytes
into CNS
Apoptosis
Drainage of
Interstitial
Fluid Capillary Venule
Entry of Lymphocytes
into CNS
Apoptosis
Drainage of
Interstitial
Fluid Capillary Venule
1995
No Continuity of CSF
with Brain:
CSF and ISF drainage
pathways are separate
Gray’s Anatomy 1995
J Anat. 2015 Nov;
227(5):702-3
Lmyphatics of the dura mater follow blood vessels exiting … through the “foro
spinoso” … of the skull. They join those coming from pterigoideal muscles and
go to the (lymphatic) glands in proximity of the internal jugular vein.
first step in neuroinflammation (postcapillary venules): the passage of T cells
and macrophages across the vascular wall is not necessarily related to pathology
Ransohoff RM,
Engelhardt B. Nat Rev
Immunol 2012;12:623
3 compartments with 7 layers separate the blood (red) from the neuropil
endothelium (grey ring), media (light blue), Virchow–Robin space (orange), glia limitans (green),
inner and outer vascular basement membranes (1 and 2, mid-blue), and the basement
membrane on top of the glia limitans (3, light blue)
A, astrocyte; B, blood; E, endothelium; GL, glia limitans; M, media; MФ, macrophage; P, pericyte; PC, perivascular cell; T, T cell; VRS,
Virchow–Robin space
First step in neuroinflammation
second step in neuroinflammation: it depends on ‘vessel-associated’ antigen-
presenting cells (JM), and ectoenzymes (MMP-2, MMP-9) that cleave components
of the third basement membrane
(perivascular restimulation of T cells is required for the induction of such ectoenzymes by T
cells or macrophages); it is possibly related to pathology
A, astrocyte; B, blood; E, endothelium; GL, glia limitans; JM, juxtavascular microglia; M, media; MФ, macrophage; P, pericyte; PC,
perivascular cell; T, T cell; VRS, Virchow–Robin space.
The Immune-privileged
Status of the Brain is
not Absolute
• Expression of MHC antigens is
very low in the CNS
• Brain cells do not normally
express MHC products which
can, however, be induced by
strong proinflammatory stimuli
(Wekerle et al., 1986: Lampson,
1987).
MHC Expression in
the Brain
• MHC-antigen expression:
• Normal conditions: no MHC expression
• Mild inflammation: microglia (Class I and II)
• Severe inflammation: neuroectodermal cells
such as astrocytes and ependymal cells (Vass
and Lassmann, 1990)
Neumann et al.,
J Exp Med. 1997 185:305
Immune-privilege in the CNS: clearance
R5
of infiltrating inflammatory cells
R5
R1
R5
R1 R1
Death receptors/ligands
Fas (CD95)/FasL (CD95L)
Complement receptors
CR1, CR3, CR4, C1qRp
Fc receptors
FCg, RI, RII, RIII
Pro-inflammatory cytokines
IL-1, IL-6, IL-12, IL-15, IL-18
Chemokines
IL-8, IP10, MIP-1a, MIP-1b,
MCP-1, Rantes, MDC, MIP3-b
Cytotoxic molecules
iNOS, nitric and oxigen radicals
Cytotoxic molecules
iNOS (a), GDN (a), oxidoreductive
enzymes (a), cathepsin D and G (a)
Recognition molecules
PSA-NCAM, NCAM (a), APP (a), G-CAM
(a), integrin, N-cadherin, laminin, tenascin
(a), proteoglycans, H-CAM (a), VCAM-I,
registering
stimulating electrode
electrode
Pharmacological isolation of GABA- and
glutamate-mediated synaptic transmssion
GABA Glutamate
in 30 µM APV in 10 µM bicuculline
+ 10 µM CNQX
X
X
Presynaptic alterations:
EAE increases the frequency of glutamatergic
spontaneous excitatory postsynaptic currents
(sEPSCs)
Expression and phosphorylation of
glutamate AMPA receptors are increased
in EAE
Arc/Arg3.1
HC
EAE 20dpi
TNF-alpha mimics the synaptic
defects of EAE mice
TNF-alpha mediates the effects of EAE and of
microglia on AMPA-mediated transmission
Conclusions
• The immune-privileged status of the CNS (and the
other immune-privileged sites) is not absolute.
• Immune reactions occur in the CNS after
inflammatory and/or degenerative stimuli.
• In response to pathogenic stimuli, CNS-resident
cells closely interact with immune-cells coming
from the peripheral circulation or resident in the
regional lymph nodes.
• Auto-immunity in the CNS may occur as a
consequence of the failure of mantainance
immune-privilege